CONAVI MEDICAL CORP. ("CONAVI MEDICAL" or the "Company"), a commercial stage company focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive ...
As many as 30% of people living with severe hemophilia A develop inhibitors such as TFPI, which can be produced by the body’s immune response to clotting factors in replacement therapy, often limiting ...